Glycemicon's Series A - II Round

Glycemicon raised a round of funding on April 03, 2018.

Glycemicon is a biotechnology company developing novel nutraceuticals for managing pre-diabetes, diabetes and obesity.…

Articles about Glycemicon's Series A - II Round: